HomeAQST • NASDAQ
add
Aquestive Therapeutics Inc
Previous close
$2.81
Day range
$2.75 - $2.86
Year range
$1.25 - $6.23
Market cap
252.18M USD
Avg Volume
1.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 12.05M | 8.25% |
Operating expense | 16.62M | 51.07% |
Net income | -12.83M | -259.00% |
Net profit margin | -106.43 | -246.88% |
Earnings per share | -0.15 | -231.46% |
EBITDA | -8.75M | -104.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 95.20M | 254.14% |
Total assets | 129.52M | 111.35% |
Total liabilities | 165.82M | -2.75% |
Total equity | -36.30M | — |
Shares outstanding | 91.04M | — |
Price to book | -7.02 | — |
Return on assets | -23.96% | — |
Return on capital | 59.72% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -12.83M | -259.00% |
Cash from operations | -10.38M | -217.79% |
Cash from investing | -29.00K | -1,350.00% |
Cash from financing | 81.74M | 988.01% |
Net change in cash | 71.33M | 18,342.46% |
Free cash flow | -5.15M | -2.91% |
About
Founded
2004
Headquarters
Website
Employees
135